Endothelial Cell-Derived Extracellular Vesicles Induce Pro-Angiogenic Responses in Mesenchymal Stem Cells

View/ Open
Access
info:eu-repo/semantics/openAccessDate
2024Author
Abdik, HüseyinKırbaş, Oğuz Kaan
Bozkurt, Batuhan Turhan
Avşar Abdik, Ezgi
Hayal, Taha Bartu
Şahin, Fikrettin
Taşlı, Pakize Neslihan
Kind
articleMetadata
Show full item recordCitation
Abdik, H., Kırbaş, O.K., Bozkurt, B.T., Avşar Abdik, E., Hayal, T.B., Şahin, F. and Taşlı, P.N. (2024), Endothelial cell-derived extracellular vesicles induce pro-angiogenic responses in mesenchymal stem cells. FEBS Open Bio, 14: 740-755. https://doi.org/10.1002/2211-5463.13650Abstract
Angiogenesis is a central component of vital biological processes such aswound healing, tissue nourishment, and development. Therefore, angio-genic activities are precisely maintained with secreted factors such asangiopoietin-1 (Ang1), fibroblast growth factor (FGF), and vascular endo-thelial growth factor (VEGF). As an element of intracellular communica-tion, extracellular vesicles (EVs)—particularly EVs of vascular origin—could have key functions in maintaining angiogenesis. However, the func-tions of EVs in the control of angiogenesis have not been fully studied. Inthis study, human umbilical vein endothelial cell line (HUVEC)-derivedsmall EVs (<200 nm; HU-sEVs) were investigated as a potential pro-angiogenic agent. Treating mesenchymal stem cells (MSCs) and matureHUVEC cells with HU-sEVs induced their tube formation under in vitroconditions and significantly increased the expression of angiogenesis-relatedgenes, such as Ang1, VEGF, Flk-1 (VEGF receptor 2), Flt-1 (VEGF recep-tor 1), and vWF (von Willebrand Factor), in a dose-dependent manner.These results indicate that HU-sEVs take part in angiogenesis activities inphysiological systems, and suggest endothelial EVs as a potential therapeu-tic candidate for the treatment of angiogenesis-related diseases.